Vergleich ver�nderter Bewu�tseinszust�nde unter den Halluzinogenen (?)-?9-trans-Tetrahydrocannabinol (?9-THC) und N,N-Dimethyltryptamin (DMT)-Reference-Cited by-同舟云学术

Vergleich ver�nderter Bewu�tseinszust�nde unter den Halluzinogenen (?)-?9-trans-Tetrahydrocannabinol (?9-THC) und N,N-Dimethyltryptamin (DMT)

Published:1976 Issue:1 Volume:223 Page:77-87
ISSN:0003-9373
Container-title:Archiv f�r Psychiatrie und Nervenkrankheiten
language:de
Short-container-title:Arch. Psychiat. Nervenkr.

Author:

Dittrich A.,Bickel P.,Sch�pf J.,Zimmer D.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF00367455.pdf

Reference27 articles.

1. Arnold, O. H., Hofmann, G.: Zur Psychopathologie des Dimethyltryptamin. Wiener Z. f. Nervenheilkunde 13, 438?445 (1957)

2. Bickel, P.: Eine experimentelle Untersuchung des Eysenckschen Drogenpostulates über Beziehungen zwischen Halluzinogenwirkung und Psychotizismus. Ein Beitrag zur Modellpsychose-Forschung. Unveröff. phil. Liz., Zürich 1975

3. Bickel, P., Dittrich, A., Schoepf, J.: Eine experimentelle Untersuchung zur bewußtseinsverändernden Wirkung von N,N-Dimethyltryptamin (DMT). Pharmakopsychiat. 9, 220?225 (1976)

4. Carlin, A. S., Post, R. D., Bakker, C. B., Halpern, L. M.: The Role of Modeling and Previous Experience in the Facilitation of Marijuana Intoxication. J. Nerv. Ment. Dis. 159, 275?281 (1974)

5. Dittrich, A.: Zusammenstellung eines Fragebogens (APZ) zur Erfassung abnormer psychischer Zustände. Z. f. Klin. Psychol. Psychother. 23, 12?20 (1975a)

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neurobiological research on N,N-dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from ayahuasca to synthetic combinations of DMT and MAO inhibitors;Cellular and Molecular Life Sciences;2024-09-10

2. Safety, tolerability, pharmacodynamic and wellbeing effects of SPL026 (dimethyltryptamine fumarate) in healthy participants: a randomized, placebo-controlled phase 1 trial;Frontiers in Psychiatry;2024-01-11

3. A Systematic Review of Study Design and Placebo Controls in Psychedelic Research;Psychedelic Medicine;2023-10-16

4. Exploratory study of the dose-related safety, tolerability, and efficacy of dimethyltryptamine (DMT) in healthy volunteers and major depressive disorder;Neuropsychopharmacology;2022-06-03

5. Hallucinations and Imagination;The Cambridge Handbook of the Imagination;2020-05-31